ET-1 actions in the kidney: Evidence for sex differences

British Journal of Pharmacology

Volumn 168, Issue 2, 2013, Pages 318-326

  Kittikulsuth, W ^a   Sullivan, J C ^a   Pollock, David M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

ET 1; hypertension; kidney; renal injury; renal medulla; sex

Indexed keywords

AMILORIDE; ATRASENTAN; AVOSENTAN; DARUSENTAN; DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR AGONIST; MESSENGER RNA; SARAFOTOXIN S6C; SITAXSENTAN; TESTOSTERONE;

ACUTE KIDNEY FAILURE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR SYSTEM; CASTRATION; CLINICAL STUDY; DISEASE COURSE; DRUG ACTIVITY; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; ECE GENE; EDN1 GENE; EDNRA GENE; ET GENE; GENETIC POLYMORPHISM; GONADECTOMY; HEART PROTECTION; HUMAN; HYDROPHOBICITY; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; INTRAVASCULAR DRUG ADMINISTRATION; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE FUNCTION; MESANGIUM CELL; NONHUMAN; PATHOGENESIS; PODOCYTE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN FUNCTION; RENAL VASCULAR SYSTEM; REVIEW; RISK REDUCTION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM EXCRETION; VASOCONSTRICTION;

ANIMALS; ENDOTHELIN-1; HUMANS; HYPERTENSION; KIDNEY; KIDNEY DISEASES; SEX CHARACTERISTICS;

EID: 84871558617     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.01922.x     Document Type: Review

References (83)

1. Abassi ZA, Golomb E, Bridenbaugh R, Keiser HR, (1993). Metabolism of endothelin-1 and big endothelin-1 by recombinant neutral endopeptidase EC.3.4.24.11. Br J Pharmacol 109: 1024-1028.
2. Ahn D, Ge Y, Stricklett PK, Gill P, Taylor D, Hughes AK, et al,. (2004). Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention. J Clin Invest 114: 504-511.
3. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S, (1990). Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732.
4. Asai T, Ohkubo T, Katsuya T, Higaki J, Fu Y, Fukuda M, et al,. (2001). Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama Study. Hypertension 38: 1321-1324.
5. Berg UB, (2006). Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors. Nephrol Dial Transplant 21: 2577-2582.
6. Binder A, (2007). A review of the genetics of essential hypertension. Curr Opin Cardiol 22: 176-184.
7. Brooks DP, Depalma PD, Pullen M, Nambi P, (1994). Characterization of canine renal endothelin receptor subtypes and their function. J Pharmacol Exp Ther 268: 1091-1097.
8. Bugaj V, Pochynyuk O, Mironova E, Vandewalle A, Medina JL, Stockand JD, (2008). Regulation of the epithelial Na+ channel by endothelin-1 in rat collecting duct. Am J Physiol Renal Physiol 295: F1063-F1070.
9. Caprioli J, Mele C, Mossali C, Gallizioli L, Giacchetti G, Noris M, et al,. (2008). Polymorphisms of EDNRB, ATG, and ACE genes in salt-sensitive hypertension. Can J Physiol Pharmacol 86: 505-510.
10. Clozel M, Clozel JP, (1989). Effects of endothelin on regional blood flows in squirrel monkeys. J Pharmacol Exp Ther 250: 1125-1131.
11. Crofton JT, Share L, (1997). Gonadal hormones modulate deoxycorticosterone-salt hypertension in male and female rats. Hypertension 29: 494-499.
12. Dhaun N, Macintyre IM, Melville V, Lilitkarntakul P, Johnston NR, Goddard J, et al,. (2009). Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-A receptor antagonism in chronic kidney disease. Hypertension 54: 113-119.
13. Edwards RM, Trizna W, Ohlstein EH, (1990). Renal microvascular effects of endothelin. Am J Physiol 259: F217-F221.
14. Fligny C, Barton M, Tharaux PL, (2011). Endothelin and podocyte injury in chronic kidney disease. Contrib Nephrol 172: 120-138.
15. Funke-Kaiser H, Reichenberger F, Kopke K, Herrmann SM, Pfeifer J, Orzechowski HD, et al,. (2003). Differential binding of transcription factor E2F-2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulation. Hum Mol Genet 12: 423-433.
16. Gariepy CE, Ohuchi T, Williams SC, Richardson JA, Yanagisawa M, (2000). Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest 105: 925-933.
17. Garvin J, Sanders K, (1991). Endothelin inhibits fluid and bicarbonate transport in part by reducing Na+/K+ ATPase activity in the rat proximal straight tubule. J Am Soc Nephrol 2: 976-982.
18. Ge Y, Stricklett PK, Hughes AK, Yanagisawa M, Kohan DE, (2005). Collecting duct-specific knockout of the endothelin A receptor alters renal vasopressin responsiveness, but not sodium excretion or blood pressure. Am J Physiol Renal Physiol 289: F692-F698.
19. Ge Y, Bagnall A, Stricklett PK, Strait K, Webb DJ, Kotelevtsev Y, et al,. (2006). Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention. Am J Physiol Renal Physiol 291: F1274-F1280.
20. Ge Y, Bagnall A, Stricklett PK, Webb D, Kotelevtsev Y, Kohan DE, (2008). Combined knockout of collecting duct endothelin A and B receptors causes hypertension and sodium retention. Am J Physiol Renal Physiol 295: F1635-F1640.
21. Gretz N, Ceccherini I, Kranzlin B, Kloting I, Devoto M, Rohmeiss P, et al,. (1995). Gender-dependent disease severity in autosomal polycystic kidney disease of rats. Kidney Int 48: 496-500.
22. Guan Z, Inscho EW, (2011). Endothelin and the renal vasculature. Contrib Nephrol 172: 35-49.
23. Herrera M, Hong NJ, Ortiz PA, Garvin JL, (2009). Endothelin-1 inhibits thick ascending limb transport via Akt-stimulated nitric oxide production. J Biol Chem 284: 1454-1460.
24. Hickey KA, Rubanyi G, Paul RJ, Highsmith RF, (1985). Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am J Physiol 248: C550-C556.
25. Hocher B, Thone-Reineke C, Rohmeiss P, Schmager F, Slowinski T, Burst V, et al,. (1997). Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 99: 1380-1389.
26. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, et al,. (1989a). The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86: 2863-2867.
27. Inoue A, Yanagisawa M, Takuwa Y, Mitsui Y, Kobayashi M, Masaki T, (1989b). The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression. J Biol Chem 264: 14954-14959.
28. Inscho EW, Imig JD, Cook AK, Pollock DM, (2005). ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin. Br J Pharmacol 146: 1019-1026.
29. Kawanishi H, Hasegawa Y, Nakano D, Ohkita M, Takaoka M, Ohno Y, et al,. (2007). Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension. Clin Exp Pharmacol Physiol 34: 280-285.
30. Kittikulsuth W, Pollock JS, Pollock DM, (2011). Sex differences in renal medullary endothelin receptor function in angiotensin II hypertensive rats. Hypertension 58: 212-218.
31. Kohan DE, (2006). The renal medullary endothelin system in control of sodium and water excretion and systemic blood pressure. Curr Opin Nephrol Hypertens 15: 34-40.
32. Kohan DE, Pritchett Y, Molitch M, Wen S, Garimella T, Audhya P, et al,. (2011a). Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy. J Am Soc Nephrol 22: 763-772.
33. Kohan DE, Rossi NF, Inscho EW, Pollock DM, (2011b). Regulation of blood pressure and salt homeostasis by endothelin. Physiol Rev 91: 1-77.
34. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al,. (2010). Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121: e46-e215.
35. Loffler BM, Breu V, Clozel M, (1993). Effect of different endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 on endothelin levels in rat plasma. FEBS Lett 333: 108-110.
36. Loutzenhiser R, Epstein M, Hayashi K, Horton C, (1990). Direct visualization of effects of endothelin on the renal microvasculature. Am J Physiol 258: F61-F68.
37. Maixnerova D, Merta M, Reiterova J, Stekrova J, Rysava R, Obeidova H, et al,. (2007). The influence of three endothelin-1 polymorphisms on the progression of IgA nephropathy. Folia Biol 53: 27-32.
38. Mann JF, Green D, Jamerson K, Ruilope LM, Kuranoff SJ, Littke T, et al,. (2010). Avosentan for overt diabetic nephropathy. J Am Soc Nephrol 21: 527-535.
39. Masaki T, Kimura S, Yanagisawa M, Goto K, (1991). Molecular and cellular mechanism of endothelin regulation. Implications for vascular function. Circulation 84: 1457-1468.
40. Montezano AC, Callera GE, Mota AL, Fortes ZB, Nigro D, Carvalho MH, et al,. (2005). Endothelin-1 contributes to the sexual differences in renal damage in DOCA-salt rats. Peptides 26: 1454-1462.
41. Morigi M, Buelli S, Zanchi C, Longaretti L, Macconi D, Benigni A, et al,. (2006). Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling. Am J Pathol 169: 1965-1975.
42. Muller V, Losonczy G, Heemann U, Vannay A, Fekete A, Reusz G, et al,. (2002). Sexual dimorphism in renal ischemia-reperfusion injury in rats: possible role of endothelin. Kidney Int 62: 1364-1371.
43. Nakano D, Pollock DM, (2009). Contribution of endothelin A receptors in endothelin 1-dependent natriuresis in female rats. Hypertension 53: 324-330.
44. Nakano D, Pollock JS, Pollock DM, (2008). Renal medullary ETB receptors produce diuresis and natriuresis via NOS1. Am J Physiol Renal Physiol 294: F1205-F1211.
45. Neugarten J, Acharya A, Silbiger SR, (2000). Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 11: 319-329.
46. Neuhofer W, Pittrow D, (2009). Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence. Eur J Clin Invest 39 (Suppl. 2): 50-67.
47. Nicaud V, Poirier O, Behague I, Herrmann SM, Mallet C, Troesch A, et al,. (1999). Polymorphisms of the endothelin-A and -B receptor genes in relation to blood pressure and myocardial infarction: the Etude Cas-Temoins sur l'Infarctus du Myocarde (ECTIM) Study. Am J Hypertens 12: 304-310.
48. Pallone TL, Robertson CR, Jamison RL, (1990). Renal medullary microcirculation. Physiol Rev 70: 885-920.
49. Park KM, Kim JI, Ahn Y, Bonventre AJ, Bonventre JV, (2004). Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem 279: 52282-52292.
50. Perico N, Cornejo RP, Benigni A, Malanchini B, Ladny JR, Remuzzi G, (1991). Endothelin induces diuresis and natriuresis in the rat by acting on proximal tubular cells through a mechanism mediated by lipoxygenase products. J Am Soc Nephrol 2: 57-69.
51. Plato CF, Pollock DM, Garvin JL, (2000). Endothelin inhibits thick ascending limb chloride flux via ET(B) receptor-mediated NO release. Am J Physiol Renal Physiol 279: F326-F333.
52. Pollock DM, Opgenorth TJ, (1993). Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation. Am J Physiol 264: R222-R226.
53. Pollock DM, Opgenorth TJ, (1994). ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney. Br J Pharmacol 111: 729-732.
54. Pollock DM, Pollock JS, (2001). Evidence for endothelin involvement in the response to high salt. Am J Physiol Renal Physiol 281: F144-F150.
55. Pollock DM, Allcock GH, Krishnan A, Dayton BD, Pollock JS, (2000). Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats. Am J Physiol Renal Physiol 278: F279-F286.
56. Pollock JS, Pollock DM, (2008). Endothelin and NOS1/nitric oxide signaling and regulation of sodium homeostasis. Curr Opin Nephrol Hypertens 17: 70-75.
57. Reckelhoff JF, Zhang H, Srivastava K, (2000). Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system. Hypertension 35: 480-483.
58. Reiterova J, Merta M, Stekrova J, Cabartova Z, Cibulka R, Maixnerova D, et al,. (2006a). Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease. Kidney Blood Press Res 29: 182-188.
59. Reiterova J, Merta M, Stekrova J, Tesar V, Kmentova D, Rihova Z, et al,. (2006b). The influence of the endothelin-converting enzyme-1 gene polymorphism on the progression of autosomal dominant polycystic kidney disease. Ren Fail 28: 21-24.
60. Reiterova J, Merta M, Stekrova J, Maixnerova D, Obeidova H, Kebrdlova V, et al,. (2007). The influence of endothelin-A receptor gene polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy. Folia Biol 53: 134-137.
61. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, et al,. (1990). Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735.
62. Sampson AK, Moritz KM, Jones ES, Flower RL, Widdop RE, Denton KM, (2008). Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female rats. Hypertension 52: 666-671.
63. Schildroth J, Rettig-Zimmermann J, Kalk P, Steege A, Fahling M, Sendeski M, et al,. (2011). Endothelin type A and B receptors in the control of afferent and efferent arterioles in mice. Nephrol Dial Transplant 26: 779-789.
64. Schneider MP, Ge Y, Pollock DM, Pollock JS, Kohan DE, (2008). Collecting duct-derived endothelin regulates arterial pressure and Na excretion via nitric oxide. Hypertension 51: 1605-1610.
65. Sokolovsky M, (1992). Structure-function relationships of endothelins, sarafotoxins, and their receptor subtypes. J Neurochem 59: 809-821.
66. Sorokin A, Kohan DE, (2003). Physiology and pathology of endothelin-1 in renal mesangium. Am J Physiol Renal Physiol 285: F579-F589.
67. Stricklett PK, Hughes AK, Kohan DE, (2006). Endothelin-1 stimulates NO production and inhibits cAMP accumulation in rat inner medullary collecting duct through independent pathways. Am J Physiol Renal Physiol 290: F1315-F1319.
68. Stringer KD, Komers R, Osman SA, Oyama TT, Lindsley JN, Anderson S, (2005). Gender hormones and the progression of experimental polycystic kidney disease. Kidney Int 68: 1729-1739.
69. Sullivan JC, Pollock JS, Pollock DM, (2006). Superoxide-dependent hypertension in male and female endothelin B receptor-deficient rats. Exp Biol Med (Maywood) 231: 818-823.
70. Sullivan JC, Semprun-Prieto L, Boesen EI, Pollock DM, Pollock JS, (2007). Sex and sex hormones influence the development of albuminuria and renal macrophage infiltration in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 293: R1573-R1579.
71. Takenaka T, Forster H, Epstein M, (1993). Protein kinase C and calcium channel activation as determinants of renal vasoconstriction by angiotensin II and endothelin. Circ Res 73: 743-750.
72. Tatchum-Talom R, Eyster KM, Martin DS, (2005). Sexual dimorphism in angiotensin II-induced hypertension and vascular alterations. Can J Physiol Pharmacol 83: 413-422.
73. Taylor TA, Gariepy CE, Pollock DM, Pollock JS, (2003). Gender differences in ET and NOS systems in ETB receptor-deficient rats: effect of a high salt diet. Hypertension 41: 657-662.
74. Tiret L, Poirier O, Hallet V, Mcdonagh TA, Morrison C, Mcmurray JJ, et al,. (1999). The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 33: 1169-1174.
75. Torres VE, Harris PC, (2009). Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 76: 149-168.
76. Tostes RC, Fortes ZB, Callera GE, Montezano AC, Touyz RM, Webb RC, et al,. (2008). Endothelin, sex and hypertension. Clin Sci (Lond) 114: 85-97.
77. Vassileva I, Mountain C, Pollock DM, (2003). Functional role of ETB receptors in the renal medulla. Hypertension 41: 1359-1363.
78. Weber MA, Black H, Bakris G, Krum H, Linas S, Weiss R, et al,. (2009). A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial. Lancet 374: 1423-1431.
79. Wenzel RR, Littke T, Kuranoff S, Jurgens C, Bruck H, Ritz E, et al,. (2009). Avosentan reduces albumin excretion in diabetics with macroalbuminuria. J Am Soc Nephrol 20: 655-664.
80. Yamamoto T, Uemura H, (1998). Distribution of endothelin-B receptor-like immunoreactivity in rat brain, kidney, and pancreas. J Cardiovasc Pharmacol 31 (Suppl. 1): S207-S211.
81. Yanagisawa M, Inoue A, Ishikawa T, Kasuya Y, Kimura S, Kumagaye S, et al,. (1988a). Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci USA 85: 6964-6967.
82. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al,. (1988b). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
83. Zeidel ML, Brady HR, Kone BC, Gullans SR, Brenner BM, (1989). Endothelin, a peptide inhibitor of Na(+)-K(+)-ATPase in intact renaltubular epithelial cells. Am J Physiol 257: C1101-C1107.